
Surgery
Mainly used for localised NSCLC that can be removed safely. It may involve removing a small part of the lung, one lobe or, less commonly, an entire lung. Nearby lymph nodes are also assessed.

From your first decision to your final treatment session, experience care that considers your breathing, strength, nutrition, comfort and overall wellbeing.

A diagnosis can bring many questions at once. Let us begin with the basics.
Lung cancer develops when abnormal cells grow uncontrollably in the lungs. There are two main categories: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
NSCLC includes adenocarcinoma, squamous cell carcinoma and large cell carcinoma. Small cell lung cancer usually grows and spreads more rapidly and is treated differently.
Smoking causes most lung cancers, but people who have never smoked can also develop the disease.
Possible symptoms include a persistent cough, breathlessness, chest discomfort, coughing up blood, unexplained weight loss or repeated chest infections. Some lung cancers are discovered during imaging before symptoms appear.
Diagnosis usually involves imaging followed by a biopsy. For many patients with NSCLC, biomarker testing is also important because specific molecular changes can influence treatment.
Your oncology team may have discussed surgery, radiation therapy, chemotherapy, targeted therapy or immunotherapy. It is completely normal to feel overwhelmed by the number of tests, appointments and treatment decisions involved. The treatment plan depends on: Whether the cancer is non-small cell or small cell The cancer’s stage Whether the tumour can be removed surgically Biomarker and PD-L1 test results Lung and heart function Symptoms and general health Previous treatments Your preferences and treatment goals

Cancer Healer Therapy (CAM) is positioned as supportive integrative care used alongside the treatment prescribed by your oncologist, not instead of it.
The supportive plan may consider concerns such as appetite, fatigue, sleep, emotional wellbeing, treatment-related discomfort and the practical challenges of living with breathing symptoms or ongoing cancer treatment.
Herbal products and dietary supplements can interact with chemotherapy, immunotherapy, targeted therapy and other medicines. They may change how a medicine is absorbed, processed or removed from the body. Every product should therefore be reviewed with the treating oncologist or oncology pharmacist before it is started.
Support may begin before surgery, chemotherapy, radiation therapy, targeted therapy or immunotherapy, with attention to: Current breathing symptoms Appetite and body weight Strength and activity level Lung and heart conditions Existing medicines and supplements Sleep and emotional wellbeing Planned treatment and possible side effects Patients preparing for surgery may also undergo lung-function and heart assessments to determine whether an operation can be performed safely.
Supportive care may focus on concerns such as: Fatigue Reduced appetite Nausea Changes in taste Difficulty maintaining weight Cough or breathlessness Sleep disturbance Treatment-related pain Anxiety about scans or treatment results New or worsening breathing problems should be reported promptly. Sudden severe breathlessness, chest pain, coughing up significant amounts of blood, confusion or bluish lips requires urgent medical attention.
If you are still considering treatment options, the first priority is to confirm the cancer type and stage and complete any recommended biomarker testing. Cancer Healer Therapy should not delay surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy or any investigation recommended by your oncology team.
Cancer Healer Therapy does not replace surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, respiratory procedures or palliative care. Patients continue their prescribed cancer treatment, and all herbal products, supplements and complementary practices should be disclosed to the treating team. No special diet, vitamin, mineral, supplement or herbal product has been proven to cure lung cancer. Some products may interfere with cancer treatment or increase the risk of side effects.

NSCLC is staged using the TNM system.

Cancer that has spread may also cause bone pain, headaches, weakness or other neurological symptoms.
Persistent cough, coughing up blood or unexplained breathlessness should be medically evaluated.


Here’s exactly what happens from your first conversation with us to ongoing support during treatment.
We discuss your diagnosis, biopsy report, scans, symptoms and current or planned oncology treatment.
The team reviews: Whether the cancer is non-small cell or small cell The histological subtype The cancer’s stage Biomarker and PD-L1 test results Surgery, radiation or systemic treatment plans Current breathing symptoms Appetite and body weight Existing lung or heart conditions Current medicines and supplements Emotional and practical needs
The supportive plan is developed around the conventional treatment you are already receiving or preparing to begin.
All herbal products, supplements, special diets and complementary practices should be disclosed to the treating oncologist so that possible interactions and contraindications can be reviewed.
The supportive plan is reviewed as treatment progresses and may be adjusted according to symptoms, nutritional needs, laboratory results, scans, treatment effects and changes made by the oncology team.
You receive one point of contact for appointments, follow-up discussions and communication related to your supportive-care plan.

Meet Dr. Tarang Krishna, MD - Cancer Healer Center
Dr. Tarang Krishna has spent over two decades developing and refining Cancer Healer Therapy, working with a multidisciplinary team across 30+ centres in India.
His work has been recognised for innovative cancer care and brings a coordinated, supportive approach to every patient journey.

Every cancer journey is personal. Read experiences shared by patients and families about the consultations, communication, follow-up and support they received at Cancer Healer Center.
4.9 Stars | 5479 Reviews
No. They are two different categories of lung cancer.
Non-small cell lung cancer includes adenocarcinoma, squamous cell carcinoma and large cell carcinoma. Small cell lung cancer usually grows and spreads more rapidly and is commonly treated with chemotherapy, radiation therapy and immunotherapy rather than surgery.
Yes. Smoking is the most important risk factor, but lung cancer can also occur in people who have never smoked.
Other risk factors include secondhand smoke, radon, air pollution, previous chest radiation and occupational exposure to substances such as asbestos, arsenic, chromium, nickel, beryllium and diesel-related pollutants.
No. Most persistent coughs are caused by infections, asthma, chronic lung disease, acid reflux or other non-cancerous conditions.
However, a cough that does not improve, becomes worse, produces blood or occurs with breathlessness, chest pain, unexplained weight loss or recurrent pneumonia should be medically evaluated.
Biomarker testing can identify molecular changes that may be treated with a matching targeted medicine.
It can also help determine whether immunotherapy is appropriate. Biomarker testing is particularly important for many patients with advanced non-small cell lung cancer.
No. Surgery is mainly used when non-small cell lung cancer is localised and the patient has sufficient lung and heart function to tolerate the operation.
Locally advanced or metastatic disease is more often treated with radiation therapy, chemotherapy, targeted therapy, immunotherapy or a combination of treatments. Surgery is used only rarely for small cell lung cancer.
No. Cancer Healer Therapy is intended to be used as supportive integrative care alongside treatment prescribed by your oncologist.
It should not replace or delay surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, respiratory procedures or palliative care.
Yes. Treatment for advanced lung cancer may help shrink or control the cancer, relieve symptoms and maintain quality of life.
The treatment choice depends on whether the cancer is non-small cell or small cell, its biomarker profile, the organs involved, previous treatment, symptoms and general health.
Important risk factors include:
Smoking remains the most important preventable risk factor. Stopping smoking can reduce future risk and may also improve health after a lung cancer diagnosis.
No. Screening is intended for people who do not have symptoms but are considered at increased risk.
Low-dose CT is the screening method shown to reduce lung cancer mortality in appropriately selected high-risk people. A person with symptoms such as coughing up blood or persistent breathlessness needs diagnostic assessment rather than routine screening.
Only after discussing every product with your oncologist or oncology pharmacist.
Herbs, supplements, teas and concentrated food products can interact with chemotherapy, targeted therapy, immunotherapy and other medicines. Some may increase side effects or alter the amount of cancer medicine in the body.